Responders, N = 14 (58.3%) | Non-responders, N = 10 (41.7%) | t or χ 2 (df = 1) | P value | |
---|---|---|---|---|
Weight (in kg) | 65.5 ± 11.23 | 65.90 ± 13.12 | 22 | NS |
Clinical features (%) | ||||
HAM-D total score | 1.71 ± 1.32 | 13.70 ± 5.14 | 8.405 | 0.001 |
HAM-A total score | 2.93 ± 2.05 | 14.80 ± 4.21 | 9.182 | 0.001 |
YMRS total score | 3.21 ± 5.76 | 2.40 ± .843 | -0.440 | NS |
ASEX total score | 12.71 ± 1.89 | 18.58 ± 4.87 | 5.129 | 0.001 |
Side effects profile (%) | ||||
Diarrhea | 0 | 0 | - | - |
Tremors | 0 | 0 | - | - |
Poor coordination | 0 | 2 (8.3%) | 3.055 | NS |
Dizziness | 0 | 0 | - | - |
Blurred vision | 0 | 0 | - | - |
Ringing in ears | 0 | 0 | - | - |
Difficult urination | 0 | 4 (16.7%) | 6.720 | 0.010 |
Painful urination | 0 | 0 | - | - |
Pollachiuria | 0 | 4 (16.7%) | 6.720 | 0.010 |
Menstrual irregularity | 0 | 0 | - | - |
Insomnia | 2 (8.3%) | 4 (16.7%) | 2.057 | NS |
Hypersomnia | 0 | 2 (8.3%) | 3.055 | NS |
Loss of libido | 0 | 8 (33.3%) | 16.800 | 0.001 |
Anorgasmy | 0 | 6 (25%) | 11.200 | 0.001 |
Erectile dysfunction | 0 | 0 | - | - |
Poor concentration | 0 | 10 (41.7%) | 24.000 | 0.001 |
General malaise | 0 | 6 (25%) | 11.200 | 0.001 |
Reduced energy | 0 | 10 (41.7%) | 24.000 | 0.001 |
Hyperphagia | 0 | 0 | - | - |